BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24927850)

  • 1. Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality.
    Tuppin P; Samson S; Fagot-Campagna A; Lukacs B; Alla F; ; Paccaud F; Thalabard JC; Vicaut E; Vidaud M; Millat B
    BMC Urol; 2014 Jun; 14():48. PubMed ID: 24927850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical prostatectomy versus deferred treatment for localised prostate cancer.
    Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
    J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.
    Potosky AL; Legler J; Albertsen PC; Stanford JL; Gilliland FD; Hamilton AS; Eley JW; Stephenson RA; Harlan LC
    J Natl Cancer Inst; 2000 Oct; 92(19):1582-92. PubMed ID: 11018094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is a treatment delay in radical prostatectomy safe in individuals with low-risk prostate cancer?
    Sun M; Abdollah F; Hansen J; Trinh QD; Bianchi M; Tian Z; Briganti A; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    J Sex Med; 2012 Nov; 9(11):2961-9. PubMed ID: 22672479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity.
    Nepple KG; Stephenson AJ; Kallogjeri D; Michalski J; Grubb RL; Strope SA; Haslag-Minoff J; Piccirillo JF; Ciezki JP; Klein EA; Reddy CA; Yu C; Kattan MW; Kibel AS
    Eur Urol; 2013 Sep; 64(3):372-8. PubMed ID: 23506834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review.
    Wallis CJD; Glaser A; Hu JC; Huland H; Lawrentschuk N; Moon D; Murphy DG; Nguyen PL; Resnick MJ; Nam RK
    Eur Urol; 2018 Jan; 73(1):11-20. PubMed ID: 28610779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancer.
    Bandini M; Marchioni M; Preisser F; Zaffuto E; Tian Z; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    World J Urol; 2018 Sep; 36(9):1399-1407. PubMed ID: 29717358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis.
    Abdollah F; Schmitges J; Sun M; Jeldres C; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    Int J Urol; 2012 Sep; 19(9):836-44. PubMed ID: 22574746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer.
    Kyrdalen AE; Dahl AA; Hernes E; Småstuen MC; Fosså SD
    BJU Int; 2013 Feb; 111(2):221-32. PubMed ID: 22672151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based study of long-term functional outcomes after prostate cancer treatment.
    Carlsson S; Drevin L; Loeb S; Widmark A; Lissbrant IF; Robinson D; Johansson E; Stattin P; Fransson P
    BJU Int; 2016 Jun; 117(6B):E36-45. PubMed ID: 25959859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study.
    Nam RK; Cheung P; Herschorn S; Saskin R; Su J; Klotz LH; Chang M; Kulkarni GS; Lee Y; Kodama RT; Narod SA
    Lancet Oncol; 2014 Feb; 15(2):223-31. PubMed ID: 24440474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of erectile dysfunction after prostate cancer treatment: cross-sectional surveys of the perceptions and experiences of patients and healthcare professionals in the UK.
    Dyer A; Kirby M; White ID; Cooper AM
    BMJ Open; 2019 Oct; 9(10):e030856. PubMed ID: 31585974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PSA testing, biopsy and cancer and benign prostate hyperplasia in France].
    Tuppin P; Samson S; Fagot-Campagna A; Lukacs B; Alla F; Allemand H; Paccaud F; Thalabard JC; Vicaut E; Vidaud M; Millat B
    Prog Urol; 2014 Jul; 24(9):572-80. PubMed ID: 24975792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone Therapy.
    Berlin A; Moraes FY; Sanmamed N; Glicksman R; Koven A; Espin-Garcia O; Leite ETT; Silva JLF; Gadia R; Nesbitt M; Catton CN; Kaffenberger S; Salami SS; Morgan TM; Hearn JWD; Jackson WC; Mehra R; Chung P; Fleshner NE; Zumsteg ZS; Dess RT; Feng FY; Finelli A; Spratt DE
    J Urol; 2019 Feb; 201(2):284-291. PubMed ID: 30153435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
    Kishan AU; Cook RR; Ciezki JP; Ross AE; Pomerantz MM; Nguyen PL; Shaikh T; Tran PT; Sandler KA; Stock RG; Merrick GS; Demanes DJ; Spratt DE; Abu-Isa EI; Wedde TB; Lilleby W; Krauss DJ; Shaw GK; Alam R; Reddy CA; Stephenson AJ; Klein EA; Song DY; Tosoian JJ; Hegde JV; Yoo SM; Fiano R; D'Amico AV; Nickols NG; Aronson WJ; Sadeghi A; Greco S; Deville C; McNutt T; DeWeese TL; Reiter RE; Said JW; Steinberg ML; Horwitz EM; Kupelian PA; King CR
    JAMA; 2018 Mar; 319(9):896-905. PubMed ID: 29509865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer.
    Berg S; Cole AP; Krimphove MJ; Nabi J; Marchese M; Lipsitz SR; Noldus J; Choueiri TK; Kibel AS; Trinh QD
    Eur Urol; 2019 Apr; 75(4):552-555. PubMed ID: 30420255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Patient Burden of Bladder Outlet Obstruction after Prostate Cancer Treatment.
    Liberman D; Jarosek S; Virnig BA; Chu H; Elliott SP
    J Urol; 2016 May; 195(5):1459-1463. PubMed ID: 26682759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sexual dysfunctions linked with prostatic diseases].
    Rouprêt M; Seisen T; De La Taille A; Desgrandchamps F
    Prog Urol; 2012 Jun; 22 Suppl 1():S14-20. PubMed ID: 22770495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.